Home About Latest Browse RSS Advanced Search

Federal Reserve Bank of Richmond
Econ Focus
Medicine Markup: Americans pay a lot for prescription drugs. Does that mean we pay too much?
Jessica Sackett Romero

Diabetics rationing their insulin because they can't afford the full dose. Senior citizens choosing between filling their prescriptions and buying groceries. Parents hoping an expired EpiPen will still work if their child has an allergic reaction.

Stories about Americans unable to pay the high cost of prescription drugs are not new. But in recent years, drug prices have drawn increased attention from policymakers on both sides of the aisle, prompted by the advent of expensive new treatments for Hepatitis C, cancer, and other illnesses, as well as steep price increases for existing treatments such as EpiPens and insulin. Prices look especially high when compared to those in many other developed countries, particularly in Europe.

Download Full text
Cite this item
Jessica Sackett Romero, "Medicine Markup: Americans pay a lot for prescription drugs. Does that mean we pay too much?" , Federal Reserve Bank of Richmond, Econ Focus, issue 4Q, pages 10-14, 2017.
More from this series
JEL Classification:
Subject headings:
Keywords: prescription drugs; price regulation; costs
For corrections, contact Christian Pascasio ()
Fed-in-Print is the central catalog of publications within the Federal Reserve System. It is managed and hosted by the Economic Research Division, Federal Reserve Bank of St. Louis.

Privacy Legal